Oncocyte
Ekkehard (Ekke) joined Oncocyte in April 2021 through the acquisition of Chronix Biomedical. Ekke serves as the managing director of Chronix Biomedical GmbH, wholly owned by Oncocyte and CMO for Europe. As an adjunct professor, he teaches molecular genetics and diagnostics at the Georg-August-University.
This person is not in any offices
Oncocyte
Oncocyte’s mission is to provide tests to physicians and patients that provide answers at critical decision points during a lung cancer diagnosis.